Multiple sclerosis (MS) is more common in western countries with diet being a potential
contributing factor. Here we show that intermittent fasting (IF) ameliorated clinical course and …

We report the results of a meta-analysis of genome-wide association scans for multiple
sclerosis (MS) susceptibility that includes 2,624 subjects with MS and 7,220 control subjects. …

The triggering receptor expressed on myeloid cells 2 (TREM-2) delivers intracellular signals
through the adaptor DAP12 to regulate myeloid cell function both within and outside the …

Chemokines trigger rapid integrin-dependent lymphocyte arrest to vascular endothelium.
We show that the chemokines SLC, ELC, and SDF-1α rapidly induce lateral mobility and …

Dietary interventions have not been effective in the treatment of multiple sclerosis (MS). Here,
we show that periodic 3-day cycles of a fasting mimicking diet (FMD) are effective in …

The triggering receptor expressed on myeloid cells 2 (TREM2) is a microglial innate immune
receptor associated with a lethal form of early, progressive dementia, Nasu-Hakola disease…

Low frequency coding variants in TREM2 are associated with increased Alzheimer disease (AD)
risk, while loss of functions mutations in the gene lead to an autosomal recessive early-…

Multiple sclerosis (MS) is an inflammatory, demyelinating, and neurodegenerative disease
of the central nervous system (CNS) triggered by autoimmune mechanisms. Microglia are …

Caloric restriction is known to improve inflammatory and autoimmune diseases. However,
the mechanisms by which reduced caloric intake modulates inflammation are poorly …

Triggering receptor expressed on myeloid cells (TREM‐2) is a membrane receptor associated
with DAP12 that is expressed primarily in myeloid cells, including dendritic cells and …